DD128131A5 - Verfahren zur herstellung von thieno(3,2-c)pyridinderivaten - Google Patents

Verfahren zur herstellung von thieno(3,2-c)pyridinderivaten

Info

Publication number
DD128131A5
DD128131A5 DD7700197020A DD19702077A DD128131A5 DD 128131 A5 DD128131 A5 DD 128131A5 DD 7700197020 A DD7700197020 A DD 7700197020A DD 19702077 A DD19702077 A DD 19702077A DD 128131 A5 DD128131 A5 DD 128131A5
Authority
DD
German Democratic Republic
Prior art keywords
thieno
preparation
pyridine derivatives
pyridine
derivatives
Prior art date
Application number
DD7700197020A
Other languages
German (de)
English (en)
Inventor
Daniel Frehel
Jean-Pierre Maffrand
Original Assignee
Parcor Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parcor Paris filed Critical Parcor Paris
Publication of DD128131A5 publication Critical patent/DD128131A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD7700197020A 1976-01-22 1977-01-20 Verfahren zur herstellung von thieno(3,2-c)pyridinderivaten DD128131A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7601637A FR2338703A1 (fr) 1976-01-22 1976-01-22 Derives de thieno (3,2-c) pyridine, leur procede de preparation et leurs applications

Publications (1)

Publication Number Publication Date
DD128131A5 true DD128131A5 (de) 1977-11-02

Family

ID=9168219

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7700197020A DD128131A5 (de) 1976-01-22 1977-01-20 Verfahren zur herstellung von thieno(3,2-c)pyridinderivaten

Country Status (32)

Country Link
US (1) US4136186A (xx)
JP (1) JPS5291891A (xx)
AR (1) AR215611A1 (xx)
AT (1) AT352729B (xx)
AU (1) AU509528B2 (xx)
BE (1) BE850620A (xx)
CA (1) CA1072097A (xx)
CH (1) CH618173A5 (xx)
DD (1) DD128131A5 (xx)
DE (1) DE2701511A1 (xx)
DK (1) DK147825C (xx)
ES (1) ES455023A1 (xx)
FI (1) FI61901C (xx)
FR (1) FR2338703A1 (xx)
GB (1) GB1529527A (xx)
GR (1) GR62519B (xx)
HU (1) HU172514B (xx)
IE (1) IE44305B1 (xx)
IL (1) IL51274A (xx)
LU (1) LU76561A1 (xx)
MX (1) MX3945E (xx)
NL (1) NL7700201A (xx)
NO (1) NO770188L (xx)
NZ (1) NZ183141A (xx)
PH (1) PH14709A (xx)
PL (1) PL101879B1 (xx)
PT (1) PT66073B (xx)
RO (1) RO69711A (xx)
SE (1) SE421700B (xx)
SU (1) SU656521A3 (xx)
YU (1) YU39789B (xx)
ZA (1) ZA77307B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495157A1 (fr) * 1980-11-28 1982-06-04 Sanofi Sa Procede nouveau de preparation des tetrahydro-5, 6, 7, 7a 4h-thieno (3, 2-c) pyridinones-2
US4775757A (en) * 1986-09-22 1988-10-04 Ortho Pharmaceutical Corporation Thienopyridines useful as cardiovascular agents
FI101150B (fi) * 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
US5296603A (en) * 1992-06-08 1994-03-22 Fuji Photo Film Co., Ltd. 3-amino-5-o-chlorobenzyl-4,5,6,7-tetrahydrothieno[3,2-c]-pyridine-2-carboxylic acid compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075215A (en) * 1973-02-01 1978-02-21 Centre D'etudes Pour L'industrie Pharmaceutique Thieno-pyridine derivatives
FR2215948B1 (xx) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma

Also Published As

Publication number Publication date
NL7700201A (nl) 1977-07-26
LU76561A1 (xx) 1977-06-17
GB1529527A (en) 1978-10-25
PL195466A1 (pl) 1978-02-27
AU2154977A (en) 1978-07-27
MX3945E (es) 1981-10-08
FR2338703B1 (xx) 1979-10-05
AT352729B (de) 1979-10-10
YU39789B (en) 1985-04-30
DE2701511A1 (de) 1977-07-28
CH618173A5 (xx) 1980-07-15
PH14709A (en) 1981-11-13
FI770180A (xx) 1977-07-23
FI61901B (fi) 1982-06-30
ES455023A1 (es) 1977-12-16
RO69711A (ro) 1980-08-15
ZA77307B (en) 1977-11-30
IE44305L (en) 1977-07-22
IE44305B1 (en) 1981-10-07
AR215611A1 (es) 1979-10-31
HU172514B (hu) 1978-09-28
PT66073A (fr) 1977-02-01
SE421700B (sv) 1982-01-25
FR2338703A1 (fr) 1977-08-19
IL51274A (en) 1981-03-31
SU656521A3 (ru) 1979-04-05
DK21477A (da) 1977-07-23
CA1072097A (en) 1980-02-19
IL51274A0 (en) 1977-03-31
US4136186A (en) 1979-01-23
DK147825B (da) 1984-12-17
PL101879B1 (pl) 1979-02-28
BE850620A (fr) 1977-07-22
SE7700572L (sv) 1977-07-23
PT66073B (fr) 1978-06-26
ATA19777A (de) 1979-03-15
YU4277A (en) 1982-06-30
DK147825C (da) 1985-06-10
NO770188L (no) 1977-07-25
NZ183141A (en) 1978-09-25
GR62519B (en) 1979-05-02
FI61901C (fi) 1982-10-11
AU509528B2 (en) 1980-05-15
JPS5291891A (en) 1977-08-02

Similar Documents

Publication Publication Date Title
AT377522B (de) Verfahren zur herstellung von furo-(3,4-c)pyridinderivaten
DD134526A5 (de) Verfahren zur herstellung von alkyloxinderivaten der 7-aminothiazolylazetamidozephalosporansaeure
DD137225A5 (de) Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten
DD131559A5 (de) Verfahren zur herstellung von thieno-(2,3-c)-und-(3,2-c
AT352875B (de) Verfahren zur herstellung von neuen 4-oxa-1- azabicyclo-(3,2,0)heptan-7-onderivaten
DD137438A5 (de) Verfahren zur herstellung von n'-phenyl-n-methylharnstoffderivaten
DD133673A5 (de) Verfahren zur herstellung von 4,5,6,7-tetrahydrothieno(2,3-c)-und-(3,2-c)pyridinen
DD135387A5 (de) Verfahren zur herstellung von thieno(2,3-c)-und-(3,2-c)pyridinen
ATA518975A (de) Verfahren zur herstellung von thieno (3,2-c) pyridin
DD132429A5 (de) Verfahren zur herstellung von derivaten von phenoxyalkansaeuren
DD136838A5 (de) Verfahren zur herstellung von thienopyridinderivaten
DD129791A5 (de) Verfahren zur herstellung von naphtyridinderivaten
DD136832A5 (de) Verfahren zur herstellung von 1,2-dichloraethan
DD129446A5 (de) Verfahren zur herstellung von benzodiazepinderivaten
AT362372B (de) Verfahren zur herstellung von thieno(2,3-c)- und thieno(3,2-c)pyridinen
DD128131A5 (de) Verfahren zur herstellung von thieno(3,2-c)pyridinderivaten
ATA706577A (de) Verfahren zur herstellung von substituierten 1-carbamoyl-2-cyanaziridinen
AT347464B (de) Verfahren zur herstellung von thieno(3,2-c) pyridin-verbindungen
ATE12772T1 (de) Verfahren zur herstellung von 5,6,7,7a-tetrahydro-4h-tieno (3,2-c) pyridin-2-onderivaten.
ATA55178A (de) Verfahren zur herstellung von 1alpha-hydroxy- -cholesterin-derivaten
DD132495A5 (de) Verfahren zur herstellung von 6a,10a-cis-hexahydrodibenzopyranonen
AT345831B (de) Verfahren zur herstellung von 4,5,6,7- tetrahydrothieno (3,2-c) pyridinderivaten
DD134522A5 (de) Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten
DD129785A5 (de) Verfahren zur herstellung von indazolderivaten
DD132496A5 (de) Verfahren zur kontinuierlichen herstellung von 2,5-dioxo-1-oxa-2-phospholanen